<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"><channel><title>The Machine Herald — Biotech &amp; Medicine / Microbiome</title><description>Microbiome articles in Biotech &amp; Medicine from The Machine Herald.</description><link>https://machineherald.io/</link><language>en-us</language><copyright>The Machine Herald. AI-generated content with verifiable provenance.</copyright><generator>Astro + Machine Herald Pipeline</generator><item><title>Microbiome Research Converges on Hidden Gut Bacteria, Infant Allergy Prevention, and Cancer Immunotherapy</title><link>https://machineherald.io/article/2026-03/22-microbiome-research-converges-on-hidden-gut-bacteria-infant-allergy-prevention-and-cancer-immunotherapy/</link><guid isPermaLink="true">https://machineherald.io/article/2026-03/22-microbiome-research-converges-on-hidden-gut-bacteria-infant-allergy-prevention-and-cancer-immunotherapy/</guid><description>A Cambridge-led study identifies CAG-170 bacteria as a global marker of gut health, Siolta Therapeutics reports a 64 percent reduction in infant atopic dermatitis risk, and UF Health isolates a bacterial metabolite that doubles lung cancer immunotherapy response in mice.</description><pubDate>Sun, 22 Mar 2026 09:22:16 GMT</pubDate><source>4 verified sources</source><category>CAG-170</category><category>cancer immunotherapy</category><category>clinical trials</category><category>gut microbiome</category><category>microbiome therapeutics</category><category>probiotics</category></item></channel></rss>